AddLife acquisition of Italian SIAD Healthcare s.p.a. business of advanced surgery has been completed

On 18 September 2020 AddLife signed an agreement on the acquisition of SIAD Healthcare s.p.a. business in the product area of advanced surgery, with sales of approximately EUR 8 million. The acquisition has been approved by the Italian authorities and has been completed and becomes effective as of today, 1 December 2020.

SIAD Healthcare s.p.a. markets and sells products from leading suppliers in advanced surgery, such as neurosurgery, spinal surgery, plastic surgery, interventional radiology, as well as products for advanced wound care.

The business has 17 employees and annual sales of approximately EUR 8 million on the Italian market. In conjunction with the acquisition, the business has been transferred to a newly formed company, called Biomedica Italia s.r.l, to which AddLife now takes over.

Stockholm 1 December 2020
AddLife AB (publ.)

For further information, please contact
Kristina Willgård, CEO, AddLife AB, +46 705 10 12 23
 

AddLife is an independent player in Life Science that offers high-quality products, services and advice to both the private and public sector, mainly in the Nordic region and the rest of Europe. AddLife has about 1,000 employees in some 50 subsidiaries that operate under their own brands. The Group has annual sales of about SEK 4.5 billion. AddLife shares are listed on NASDAQ Stockholm.

This information was issued for publication on 1 December 2020 at 14:30 CET.